Abstract: The present invention provides methods of producing biologically active recombinant eFSH analogs and methods of increasing reproduction in mammals, particularly equine, using recombinant eFSH analogs. Also provided are methods of producing biologically active single chain recombinant eFSH. The recombinant eFSH analogs of the present invention increase superovulation, follicular development, embryo development, and reproductive efficiency in horses, cattle and other ungulates.

Abstract: Provided is an image processing apparatus. Ray tracing may be performed using a general scheme with respect to a plurality of reference pixels among pixels of an image to be rendered. With respect to a pixel excluding the reference pixels, geometry information may be interpolated based on a ray tracing result of adjacent reference pixels.

Abstract: Apparatuses, systems, and methods for optimal group key (OGK) management that may achieve non-colluding and/or the storage-communication optimality are disclosed. In some embodiments, a group controller (GC) is responsible for key generation and distribution and the group data are encrypted by a group key. When joining the group, in some embodiments, each group member (GM) is assigned a unique n-bit ID and a set of secrets, in which each bit is one-to-one mapped to a unique secret. Whenever GMs are revoked from the group, in some embodiments, the GC will multicast an encrypted key-update message. Only the remaining GMs may be able to recover the message and update GK as well as their private keys. The disclosed OGK scheme can achieve storage-communication optimality with constant message size and immune to collusion attack and also may outperform existing group key management schemes in terms of communication and storage efficiency.

Abstract: Disclosed are systems, apparatus, methods and devices, including a method that includes generating two or more sequential surface plasmon interference patterns, at least one of the two or more sequential surface plasmon interference patterns being different from another of the two or more sequential surface plasmon interference patterns, and capturing respective images of a specimen resulting from the interference patterns. Also disclosed is a method that includes generating two or more sequential optical interference patterns, at least one of the two or more sequential optical interference patterns being different from another of the interference patterns, and removing from each of the generated interference patterns, using a beam stopper, a corresponding zero-order diffraction light component included in the respective generated patterns to obtain resultant corresponding two or more sequential optical interference patterns, directed at a specimen, with missing respective zero-order light components.

Abstract: Provided is a system and method for processing medical information through a medical terminal. The system includes a mobile cloud system unit and a service browser unit. The service browser unit is configured as an application in a user terminal to allow a user to use a medical information processing service, and induces access to the mobile cloud system unit taking charge of medication information processing.

Abstract: The invention relates to a transponder for marking wood material and a method of manufacturing thereof. The method comprises embedding an RFID microchip and antenna into a casing essentially consisting of one or more biodegradable materials. According to the invention the embedding step comprises forming the antenna by layering conductive material directly on biodegradable material, and covering the antenna by biodegradable material. By means of the invention, environmentally friendly and pulping-compatible transponders can be manufactured, for example, for aiding the logistics of forest industry.

Abstract: The present invention is directed to heat shock proteins from Mycobacterium leprae as well as their encoding polynucleotides and vectors and host cells containing these polynucleotides. These heat shock proteins and their encoding polynucleotides are useful in detection of Mycobacterium leprae. In addition, the heat shock protein can be used as an adjuvant in a pharmaceutical composition containing an antigen to induce or enhance the immune response against the antigen. Further, the heat shock protein may be used to treat atopic conditions or as a vaccine against Mycobacterium leprae. Alternatively, the heat shock protein can be used to form a fusion protein with an antigen to induce or enhance the immune response against the antigen.

Abstract: There is provided a catalyst comprising metal nanoparticles supported on nanocrystalline cellulose and a homogeneous catalyst system comprising this catalyst colloidally suspended in a fluid. There is also provided a method of producing this catalyst and various uses thereof.

Abstract: The present invention provides compositions, methods and kits for generating synthetic genetic circuits in biological systems. In particular, the present invention provides vectors, reagents and methods of their use in constructing synthetic genetic circuits in bacteria.

Abstract: A code generator and multi-core framework are executable in a computer system to implement methods as disclosed herein, including a method for the code generator to automatically generate multi-threaded source code from functional specifications, and for the multi-core framework, which is a run time component, to generate multi-threaded task object code from the multi-threaded source code and to execute the multi-threaded task object code on respective processor cores. The methods provide transparency to the programmer, and during execution, provide automatic identification of processing parallelisms. The methods implement Consume-Simplify-Produce and Normalize-Transpose-Distribute operations to reduce complex expression sets in a functional specification to simplified expression sets operable in parallel processing environments through the generated multi-threaded task object code.

Abstract: Disclosed is a block copolymer formed by coupling the following components with each other: (a) a copolymer (A) of a polyethylene glycol (PEG) type compound with a biodegradable polymer; and (b) at least one oligomer (B) selected from the group consisting of poly(?-amino ester) and poly(amido amine). A method for preparing the same block copolymer, and a polymeric hydrogel type drug composition comprising the temperature and pH-sensitive block copolymer and a physiologically active substance that can be encapsulated with the block copolymer are also disclosed. The multiblock copolymer is obtained by copolymerization of a pH-sensitive poly(?-amino ester) and/or poly(amido amine) type oligomer, a hydrophilic and temperature-sensitive polyethylene glycol type compound and a hydrophobic and biodegradable polymer.

Abstract: The present invention is a multi-wavelength diagnostic imager. In one embodiment, the present invention includes an apparatus and method for noninvasive evaluation of a target versus a non-target, comprising: one or more light sources having at least one emission spectra directed at the target wherein the position, orientation and intensity of light sources is varied to control near-surface reflectance and are directed at less than the entire target; and one or more detectors positioned to capture light reflected from the target into two or more spatial images of the target at two or more times, wherein the spatial images are used to distinguish between the target and the non-target.

Abstract: Zwitterionic crosslinking agents, crosslinked zwitterionic hydrogels prepared from copolymerization of zwitterionic monomers with the zwitterionic crosslinking agent, methods for making crosslinked zwitterionic hydrogels, and devices that include and methods that use the crosslinked zwitterionic hydrogels.

Abstract: This invention provides RNA, oligoribonucleotide, and polyribonucleotide molecules comprising pseudouridine or a modified nucleoside, gene therapy vectors comprising same, methods of synthesizing same, and methods for gene replacement, gene therapy, gene transcription silencing, and the delivery of therapeutic proteins to tissue in vivo, comprising the molecules. The present invention also provides methods of reducing the immunogenicity of RNA, oligoribonucleotide, and polyribonucleotide molecules.

Abstract: A system comprises an injection well for accessing an underground reservoir having a first temperature. The reservoir is located below a caprock and is accessible without using large-scale hydrofracturing. The injection well includes an injection well reservoir opening in fluid communication with the reservoir. The system also includes a production well having a production well reservoir opening in fluid communication with the reservoir. A working-fluid supply system provides a non-water based working fluid to the injection well at a second temperature lower than the first temperature. Exposure of the non-water based working fluid to the first temperature produces heated non-water based working fluid capable of entering the production well reservoir opening. An energy converting apparatus connected to the productions well converts thermal energy contained in the heated non-water based working fluid to electricity, heat, or combinations thereof.

Abstract: A reflectarray, including: a substrate; and a plurality of patches formed on each of areas into which a principal surface of the substrate is divided, wherein the plurality of patches are formed by including a gap.

Abstract: Disclosed is a Thermoanaerobacter sp. bacterial strain (BKHI) isolated from a hot spring, a purified protein (bioremediase) isolated from bacterial strain BKH1, as well as concrete compositions comprising BKH1 and/or the protein, and methods of using the protein and/or composition. Also disclosed are nucleic acids encoding the protein isolated from BKHI, as well as expression vectors, host cells, cell lines, and methods for generating and purifying the bioremediase protein.

Abstract: The present invention relates to transgenic animals comprising a mutation or deletion to the ANF-RGC protein, particularly to its ARM and/or its ATS-ST region. Such animals may be used to study the effects on pathways associated with ANF-RGC activation, including, but not limited to, hypertension. Such animals may also be used in drug screen assays, to establish toxicity profiles, or other similar methods discussed herein known in the art.

Abstract: Herein provided is a new soybean variety designated ‘G03-1187RR’ as well as the seeds, plants and derivatives of the new soybean variety ‘G03-1187RR’. Also provided are tissue cultures of the new soybean variety ‘G03-1187RR’ and the plants regenerated therefrom. Methods for producing soybean plants by crossing the new soybean variety ‘G03-1187RR’ with itself or another soybean variety and plants produced by such methods are also provided.

Abstract: A new and distinct Prunus laurocerasus plant of unknown parentage is provided. The new plant can be readily distinguished from other plants of the species including the ‘Otto Luyken’ cultivar (non-patented in the United States). A slow to moderate growth habit is displayed to form a compact generally rounded plant with dense foliage. The foliage is dark green in coloration and displays more glossiness on the upper surface than commonly observed for the ‘Otto Luyken’ cultivar. Superior resistance to Coryneum blight has been observed. The new plant is well suited for providing attractive ornamentation in a hedge, foundation planting, or when grown en masse.